Literature DB >> 14620197

Review of spinal epidural cavernous hemangioma.

Norio Aoyagi1, Kuniaki Kojima, Hirohiko Kasai.   

Abstract

The characteristics of spinal epidural cavernous hemangioma without primary origin in the vertebral bone were evaluated in 54 patients including our new case. The 36 male and 18 female patients were aged 5 to 78 years (mean 47 years). Most lesions were in the thoracic spine (80%) and on the dorsal side of the spinal cord (93%). The clinical course was mostly slowly progressive, with myelopathy in 33% at onset and 83% at admission. The lesion appeared isointense to the spinal cord on T1-weighted imaging, and isointense or slightly hypointense to the cerebrospinal fluid on T2-weighted imaging. Lesion without hemorrhage showed prominent homogeneous enhancement after administration of gadolinium-diethylenetriaminepenta-acetic acid because of the sinusoidal channel structure. Heterogeneous enhancement was caused by hematoma and/or post-hemorrhagic degeneration. The differential diagnosis of this disease includes metastatic tumor, Ewing's sarcoma, chordoma, eosinophilic granuloma, sarcoidosis, lipoma, hypertrophy of the posterior longitudinal ligament or the ligamentum flavum, meningioma, and neurinoma. The relationships between clinical course and surgery or outcome suggest that early diagnosis and total removal of the lesion before massive lesional bleeding occurs are necessary for a good outcome.

Entities:  

Mesh:

Year:  2003        PMID: 14620197     DOI: 10.2176/nmc.43.471

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  26 in total

1.  A pure epidural spinal cavernous hemangioma - with an innocuous face but a perilous behaviour!!

Authors:  Hemalatha A L; Ravikumar T; Neelima P Chamarthy; Kunal Puri
Journal:  J Clin Diagn Res       Date:  2013-05-28

2.  Spontaneous spinal epidural hematoma as the initial presentation of leukemia.

Authors:  Hidetoshi Nojiri; Sungdo Kim; Takaaki Tsuji; Soichi Uta
Journal:  Eur Spine J       Date:  2009-01-06       Impact factor: 3.134

Review 3.  Solitary spinal epidural cavernous angioma: report of nine surgically treated cases and review of the literature.

Authors:  Mahmoud Reza Khalatbari; Kazem Abbassioun; Abbas Amirjmshidi
Journal:  Eur Spine J       Date:  2012-10-06       Impact factor: 3.134

4.  Spinal extradural cavernous haemangioma in an elderly man.

Authors:  Asifur Rahman; Saif Ul Hoque; Paawan Bahadur Bhandari; Abu Saleh Md Abu Obaida
Journal:  BMJ Case Rep       Date:  2012-08-08

Review 5.  [Diagnostic work-up and therapy of spinal vascular malformations: an update].

Authors:  S Eicker; B Turowski; H-J Steiger; D Hänggi
Journal:  Nervenarzt       Date:  2010-06       Impact factor: 1.214

6.  Intralesional hemorrhage and thrombosis without rupture in a pure spinal epidural cavernous angioma: a rare cause of acute lumbal radiculopathy.

Authors:  Frank Floeth; Markus Riemenschneider; Jörg Herdmann
Journal:  Eur Spine J       Date:  2010-03-07       Impact factor: 3.134

7.  Extradural spinal cavernous angiomas: report of seven cases.

Authors:  Antonio Santoro; Manolo Piccirilli; Roberto Bristot; Valerio di Norcia; Maurizio Salvati; Roberto Delfini
Journal:  Neurosurg Rev       Date:  2005-05-31       Impact factor: 3.042

8.  Clinical characteristics and surgical outcomes of solitary spinal epidural cavernous angiomas.

Authors:  Tao Yang; Fei Wang; Chaoshi Niu
Journal:  Oncol Lett       Date:  2018-02-12       Impact factor: 2.967

Review 9.  Clinical and radiological presentation of spinal epidural haemangiomas: clinical series in a tertiary care centre during a 10-year period.

Authors:  Mario Mühmer; Richard Bostelmann; Sevgi Sarikaya-Seiwert; Marcel Schneiderhan; Hans-Jakob Steiger; Jan Frederick Cornelius
Journal:  Eur Spine J       Date:  2013-10-06       Impact factor: 3.134

10.  Solitary spinal epidural cavernous haemangiomas as a rare cause of myelopathy.

Authors:  Ying Meng; Mohammed F Shamji
Journal:  BMJ Case Rep       Date:  2015-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.